A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 result (Q51858597)
Jump to navigation
Jump to search
scientific article published in March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 result |
scientific article published in March 2014 |
Statements
1 reference
A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 result (English)
1 reference
1 reference
Paul E Sax
1 reference
David A Wohl
1 reference
Calvin Cohen
1 reference
Joel E Gallant
1 reference
Edwin Dejesus
1 reference
Andrew Zolopa
1 reference
Hui C Liu
1 reference
Andrew Plummer
1 reference
Kirsten L White
1 reference
Andrew K Cheng
1 reference
Martin S Rhee
1 reference
Javier Szwarcberg
1 reference
GS-US-236-0102 Study Team
1 reference
1 March 2014
1 reference
65
1 reference
e118-20
1 reference
3
1 reference
Identifiers
1 reference